GUIDE DE LA SOCIÉTÉ

ONC HTI-1 Algorithm Transparency Rule

ONC’s HTI-1 final rule updates the Health IT Certification Program and establishes transparency requirements for predictive decision support interventions in certified health IT.

  • 3 minutes de lecture
  • Dernière mise à jour
Sur cette page3 minutes de lecture
  1. Aperçu
  2. Plongée profonde
  3. Impact stratégique
  4. The Future of ONC HTI-1 Algorithm Transparency Rule
  5. Mise en œuvre dans le monde réel
  6. Risques et garde-fous
  7. Feuille de route de mise en œuvre
  8. Continuez à explorer
  9. Questions fréquemment posées

Aperçu

The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.

Plongée profonde

The Health Data, Technology, and Interoperability (HTI-1) final rule updates ONC’s Health IT Certification Program. One part addresses algorithm transparency for predictive decision support interventions in certified health IT. ONC describes these requirements as providing clinical users with a consistent baseline of information to assess algorithms for fairness, appropriateness, validity, effectiveness, and safety. The rule focuses on certified health IT and defined predictive decision support interventions. It does not create a blanket disclosure requirement for every AI product used in healthcare. Developers must identify whether a function falls within the relevant certification criteria and provide required source attributes. Health systems should understand the certified product scope and use available documentation when evaluating a tool. Transparency supports evaluation, but disclosure alone does not show that a model performs well or is safe. Users still need to consider local population, workflow, data quality, clinical evidence, and ongoing monitoring. The rule became effective in March 2024, and organizations should check current ONC materials for implementation details and corrections. Do not confuse HTI-1 transparency requirements with FDA device authorization or other privacy and safety obligations. Implementation requires understanding whether a decision-support function is offered through certified health IT and which version is in use. A deployment may include multiple algorithms, so one disclosure should not be assumed to describe every feature. Clinicians need information in a form that supports practical review during their workflow.

Impact stratégique

Risques et sécurité

Les dommages catastrophiques et quotidiens causés par l’IA dépendent tous deux de la personne qui comprend les risques et qui peut agir.

Décisions plus claires

Les connaissances du public et des professionnels déterminent si une politique de sécurité forte est politiquement possible.

Passer à travers le battage médiatique

Des explications claires réduisent la capture par le battage médiatique, les relations publiques en laboratoire et le théâtre d'éthique vague.

The Future of ONC HTI-1 Algorithm Transparency Rule

Algorithm transparency may make it easier for clinicians to inspect baseline information about decision-support tools. It cannot replace independent evaluation, governance, or regulatory review. ONC may issue implementation updates, and certified developers may revise products. Health systems should maintain a process to review disclosures, ask vendors questions, and reassess interventions after changes. Transparent information is most useful when users can access it before relying on a recommendation and have a route to raise concerns. Support user questions promptly and clearly.

Mise en œuvre dans le monde réel

A certified EHR developer documents source attributes for a predictive decision-support function.

A clinic checks whether an algorithm is within the certified health IT scope before applying HTI-1 requirements.

A clinician reviews available information about a model’s intended use and limitations.

An implementation team maps each predictive intervention to the required transparency criteria.

Risques et garde-fous

  • Traiter le risque existentiel comme de la science-fiction alors que les capacités s’accroissent.

  • Confondre sécurité des produits de surface et alignement sous haute autonomie.

  • Laisser le public non anglophone et non expert avec uniquement des sources de mauvaise qualité.

Feuille de route de mise en œuvre

  1. Séparez les dommages causés aux produits, leur mauvaise utilisation et les risques de perte de contrôle/désalignement.

  2. Demandez quelles preuves pourraient changer votre point de vue sur les délais et la gravité.

  3. Préférez les sources primaires et les évaluations concrètes aux allégations marketing.

  4. Identifiez une voie d’action : carrière, politique, financement ou compétences – et pas seulement la sensibilisation.

Continuez à explorer

Free newsletter

Get the daily AI briefing

Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.

One email each weekday. Unsubscribe in one click. We never sell or share your address.

Test yourself

Take the ONC HTI-1 Algorithm Transparency Rule quiz

Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.

Démarrer le quiz

Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation

Questions fréquemment posées

What is ONC HTI-1 Algorithm Transparency Rule?

ONC’s HTI-1 final rule updates the Health IT Certification Program and establishes transparency requirements for predictive decision support interventions in certified health IT. The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.

What can required source attributes help users assess?

ONC describes these evaluation dimensions for clinical users.

Does HTI-1 transparency prove a model is safe?

Disclosure is not a substitute for evidence and local evaluation.

How does HTI-1 relate to FDA authorization?

HTI-1 certification and FDA device rules are distinct frameworks.